Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$0.0 - $0.18 $0 - $108,701
-603,896 Closed
0 $0
Q4 2022

Feb 14, 2023

SELL
$0.14 - $12.49 $2,482 - $221,472
-17,732 Reduced 2.85%
603,896 $90,000
Q3 2022

Nov 15, 2022

BUY
$8.51 - $13.6 $631,518 - $1.01 Million
74,209 Added 13.56%
621,628 $6.52 Million
Q2 2022

Aug 15, 2022

BUY
$7.31 - $11.85 $3.23 Million - $5.23 Million
441,221 Added 415.47%
547,419 $5.3 Million
Q1 2022

May 16, 2022

BUY
$7.35 - $10.63 $57,962 - $83,828
7,886 Added 8.02%
106,198 $873,000
Q4 2021

Feb 14, 2022

SELL
$4.19 - $9.56 $64,107 - $146,268
-15,300 Reduced 13.47%
98,312 $940,000
Q3 2021

Nov 15, 2021

SELL
$3.56 - $4.64 $65,504 - $85,376
-18,400 Reduced 13.94%
113,612 $527,000
Q2 2021

Aug 16, 2021

SELL
$3.95 - $5.41 $1.58 Million - $2.17 Million
-400,604 Reduced 75.21%
132,012 $570,000
Q1 2021

May 17, 2021

BUY
$4.52 - $7.8 $19,558 - $33,750
4,327 Added 0.82%
532,616 $2.82 Million
Q4 2020

Feb 16, 2021

SELL
$4.37 - $9.46 $54,983 - $119,025
-12,582 Reduced 2.33%
528,289 $3.72 Million
Q3 2020

Nov 10, 2020

SELL
$8.56 - $26.93 $524,300 - $1.65 Million
-61,250 Reduced 10.17%
540,871 $4.9 Million
Q2 2020

Aug 14, 2020

BUY
$21.21 - $31.55 $2.29 Million - $3.41 Million
107,955 Added 21.85%
602,121 $16.5 Million
Q1 2020

May 11, 2020

BUY
$18.43 - $38.04 $9.11 Million - $18.8 Million
494,166 New
494,166 $10.9 Million

Others Institutions Holding TCDA

About Tricida, Inc.


  • Ticker TCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,668,900
  • Market Cap $557K
  • Description
  • Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...
More about TCDA
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.